Viewing Study NCT06756269


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-01-02 @ 5:40 AM
Study NCT ID: NCT06756269
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2024-12-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years
Sponsor: Shanghai Bovax Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module